{
    "clinical_study": {
        "@rank": "134579", 
        "arm_group": [
            {
                "arm_group_label": "alirocumab SAR236553 (REGN727) Dose Regimen A", 
                "arm_group_type": "Experimental", 
                "description": "injection through subcutaneous (SC) administration"
            }, 
            {
                "arm_group_label": "alirocumab SAR236553 (REGN727) Dose Regimen B", 
                "arm_group_type": "Experimental", 
                "description": "injection through subcutaneous (SC) administration"
            }, 
            {
                "arm_group_label": "alirocumab SAR236553 (REGN727) placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo subcutaneous (SC) injection"
            }
        ], 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      To demonstrate the reduction of low-density lipoprotein cholesterol (LDL-C) by alirocumab as\n      add-on to non-statin lipid modifying background therapy or as monotherapy in comparison with\n      placebo  in patients with primary hypercholesterolemia not treated with a statin.\n\n      Secondary Objective:\n\n      To evaluate the safety and tolerability of alirocumab."
        }, 
        "brief_title": "Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypercholesterolemia", 
        "condition_browse": {
            "mesh_term": "Hypercholesterolemia"
        }, 
        "detailed_description": {
            "textblock": "Approximately 35 weeks + an optional open-label treatment period up to 120 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        Patients with primary hypercholesterolemia (heFH or non-FH) not adequately controlled with\n        their non statin lipid modifying therapy or diet.\n\n        Exclusion criteria:\n\n        LDL-C <70 mg/dL (1.81 mmol/L) and very high cardiovascular risk patients who are\n        intolerant to statins at the screening visit (Week-3, V1).\n\n        LDL-C <100 mg/dL (<2.59 mmol/L) and at high or moderate cardiovascular risk patients  at\n        the screening visit (Week-3, V1).\n\n        LDL-C \u2265 160 mg/dL (\u22654.1 mmol/L) if receiving diet only or a non-statin LMT for patients\n        not fulfilling the statin intolerant definition.\n\n        The above information is not intended to contain all considerations relevant to a\n        patient's potential participation in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023879", 
            "org_study_id": "EFC13786", 
            "secondary_id": [
                "2013-002659-14", 
                "U1111-1146-3517"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "alirocumab SAR236553 (REGN727) Dose Regimen A", 
                "description": "Pharmaceutical form:Solution for injection Route of administration: Subcutaneous", 
                "intervention_name": "alirocumab SAR236553 (REGN727) Dose Regimen A", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "alirocumab SAR236553 (REGN727) Dose Regimen B", 
                "description": "Pharmaceutical form:Solution for injection Route of administration: Subcutaneous", 
                "intervention_name": "alirocumab SAR236553 (REGN727) Dose Regimen B", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "alirocumab SAR236553 (REGN727) placebo", 
                "description": "Pharmaceutical form:Solution for injection Route of administration: Subcutaneous", 
                "intervention_name": "alirocumab matching placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beverly Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90211"
                    }, 
                    "name": "Investigational Site Number 840703"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlantis", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33462"
                    }, 
                    "name": "Investigational Site Number 840704"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32216"
                    }, 
                    "name": "Investigational Site Number 840708"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sarasota", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33579"
                    }, 
                    "name": "Investigational Site Number 840701"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fall River", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02720"
                    }, 
                    "name": "Investigational Site Number 840706"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63131"
                    }, 
                    "name": "Investigational Site Number 840705"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Investigational Site Number 840707"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Summerville", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29485"
                    }, 
                    "name": "Investigational Site Number 840702"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ashford", 
                        "country": "Australia", 
                        "zip": "5035"
                    }, 
                    "name": "Investigational Site Number 036703"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Perth", 
                        "country": "Australia", 
                        "zip": "6000"
                    }, 
                    "name": "Investigational Site Number 036702"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woolloongabba", 
                        "country": "Australia", 
                        "zip": "4102"
                    }, 
                    "name": "Investigational Site Number 036701"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Antwerpen", 
                        "country": "Belgium", 
                        "zip": "2060"
                    }, 
                    "name": "Investigational Site Number 056702"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haine-Saint-Paul", 
                        "country": "Belgium", 
                        "zip": "7100"
                    }, 
                    "name": "Investigational Site Number 056703"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }, 
                    "name": "Investigational Site Number 056701"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicoutimi", 
                        "country": "Canada", 
                        "zip": "G7H7K9"
                    }, 
                    "name": "Investigational Site Number 124703"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec", 
                        "country": "Canada", 
                        "zip": "G1V 4M6"
                    }, 
                    "name": "Investigational Site Number 124701"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sherbrooke", 
                        "country": "Canada", 
                        "zip": "J1H 1Z1"
                    }, 
                    "name": "Investigational Site Number 124704"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "zip": "M9V 4B4"
                    }, 
                    "name": "Investigational Site Number 124706"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "zip": "V5Z 1M9"
                    }, 
                    "name": "Investigational Site Number 124702"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Victoria", 
                        "country": "Canada", 
                        "zip": "V8T 5G4"
                    }, 
                    "name": "Investigational Site Number 124705"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarhus", 
                        "country": "Denmark", 
                        "zip": "8200"
                    }, 
                    "name": "Investigational Site Number 208703"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Esbjerg", 
                        "country": "Denmark", 
                        "zip": "6700"
                    }, 
                    "name": "Investigational Site Number 208702"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glostrup", 
                        "country": "Denmark", 
                        "zip": "2600"
                    }, 
                    "name": "Investigational Site Number 208701"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hvidovre", 
                        "country": "Denmark", 
                        "zip": "2650"
                    }, 
                    "name": "Investigational Site Number 208704"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f8ge", 
                        "country": "Denmark", 
                        "zip": "4600"
                    }, 
                    "name": "Investigational Site Number 208705"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Investigational Site Number 528701"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Den Helder", 
                        "country": "Netherlands", 
                        "zip": "1782 GZ"
                    }, 
                    "name": "Investigational Site Number 528708"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hoogeveen", 
                        "country": "Netherlands", 
                        "zip": "7909 AA"
                    }, 
                    "name": "Investigational Site Number 528702"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hoorn", 
                        "country": "Netherlands", 
                        "zip": "1625 HV"
                    }, 
                    "name": "Investigational Site Number 528703"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3045 PM"
                    }, 
                    "name": "Investigational Site Number 528706"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sneek", 
                        "country": "Netherlands", 
                        "zip": "8601 ZK"
                    }, 
                    "name": "Investigational Site Number 528709"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3584 CX"
                    }, 
                    "name": "Investigational Site Number 528704"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Venlo", 
                        "country": "Netherlands", 
                        "zip": "5912 BL"
                    }, 
                    "name": "Investigational Site Number 528707"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auckland", 
                        "country": "New Zealand", 
                        "zip": "1023"
                    }, 
                    "name": "Investigational Site Number 554702"
                }, 
                "status": "Completed"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Christchurch", 
                        "country": "New Zealand", 
                        "zip": "1"
                    }, 
                    "name": "Investigational Site Number 554701"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "A Coruna", 
                        "country": "Spain", 
                        "zip": "15006"
                    }, 
                    "name": "Investigational Site Number 724703"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08025"
                    }, 
                    "name": "Investigational Site Number 724707"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "Investigational Site Number 724710"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "C\u00f3rdoba", 
                        "country": "Spain", 
                        "zip": "14004"
                    }, 
                    "name": "Investigational Site Number 724702"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Granada", 
                        "country": "Spain", 
                        "zip": "18012"
                    }, 
                    "name": "Investigational Site Number 724705"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sant Joan Desp\u00ed", 
                        "country": "Spain", 
                        "zip": "08970"
                    }, 
                    "name": "Investigational Site Number 724709"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago De Compostela", 
                        "country": "Spain", 
                        "zip": "15706"
                    }, 
                    "name": "Investigational Site Number 724706"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaragoza", 
                        "country": "Spain", 
                        "zip": "50009"
                    }, 
                    "name": "Investigational Site Number 724701"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Belgium", 
                "Canada", 
                "Denmark", 
                "Netherlands", 
                "New Zealand", 
                "Spain"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Alirocumab in Patients With Primary Hypercholesterolemia Not Treated With a Statin", 
        "overall_contact": {
            "email": "Contact-Us@sanofi.com", 
            "last_name": "For site information, send an email with site number to"
        }, 
        "overall_official": {
            "affiliation": "Sanofi", 
            "last_name": "Clinical Sciences & Operations", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The percent change in  LDL-C from baseline to Week 24", 
            "safety_issue": "No", 
            "time_frame": "At 24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023879"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Safety parameters (adverse events, cardiovascular events, laboratory data, vital signs, and ECG) assessed throughout the study", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to week 24"
            }, 
            {
                "measure": "The percent change in Apolipoprotein B (ApoB)", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to week 24"
            }, 
            {
                "measure": "The percent change in non-high density lipoprotein cholesterol (non-HDL-C)", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to week 24"
            }, 
            {
                "measure": "The percent change in Total-Cholesterol (TC)", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to week 24"
            }, 
            {
                "measure": "The percent change in Lipoprotein (a) (Lp[a])", 
                "safety_issue": "Yes", 
                "time_frame": "From baseline up to week 24"
            }, 
            {
                "measure": "The percent change in high-density lipoprotein cholesterol (HDL-C)", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to week 24"
            }, 
            {
                "measure": "The percent change in Triglyceride (TG)", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to week 24"
            }, 
            {
                "measure": "The percent change in Apolipoprotein A-1 (Apo A-1) levels", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to week 24"
            }
        ], 
        "source": "Sanofi", 
        "sponsors": {
            "collaborator": {
                "agency": "Regeneron Pharmaceuticals", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}